This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1973 Mar;21(3):337-42.

doi: 10.1016/0014-2999(73)90136-2.

Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests

W D Horst, W R Pool, H E Spiegel

PMID: 4736076
DOI: 10.1016/0014-2999(73)90136-2

Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests

W D Horst et al. Eur J Pharmacol. 1973 Mar.

. 1973 Mar;21(3):337-42.

doi: 10.1016/0014-2999(73)90136-2.

Authors

W D Horst, W R Pool, H E Spiegel

PMID: 4736076
DOI: 10.1016/0014-2999(73)90136-2

No abstract available

PubMed Disclaimer

Similar articles

Synthesis and antireserpine activity of peptides of L-dopa.
Felix AM, Winter DP, Wang SS, Kulesha ID, Pool WR, Hane DL, Sheppard H. Felix AM, et al. J Med Chem. 1974 Apr;17(4):422-6. doi: 10.1021/jm00250a011. J Med Chem. 1974. PMID: 4857423 No abstract available.
Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
Ahlenius S. Ahlenius S. Neuropharmacology. 1974 Aug;13(8):729-39. doi: 10.1016/0028-3908(74)90019-7. Neuropharmacology. 1974. PMID: 4444759 No abstract available.
L-DOPA: chemical modifications and biological evaluation.
Brossi A, Pool W, Sheppard H, Burns JJ, Kaiser A, Bigler R, Bartholini G, Pletscher A. Brossi A, et al. Adv Neurol. 1974;5:291-3. Adv Neurol. 1974. PMID: 4474795 No abstract available.
Biochemical and pharmacological aspects of Parkinsonism.
Carlsson A. Carlsson A. Acta Neurol Scand Suppl. 1972;51:11-42. Acta Neurol Scand Suppl. 1972. PMID: 4351191 Review. No abstract available.
Recent advances in the treatment of Parkinsonism with drugs.
Rinne UK. Rinne UK. Acta Neurol Scand Suppl. 1972;51:59-103. Acta Neurol Scand Suppl. 1972. PMID: 4576076 Review. No abstract available.

See all similar articles

Cited by

Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice.
Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, Wess J. Gomeza J, et al. Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1692-7. doi: 10.1073/pnas.96.4.1692. Proc Natl Acad Sci U S A. 1999. PMID: 9990086 Free PMC article.
Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.
Gerlach M, Riederer P. Gerlach M, et al. J Neural Transm (Vienna). 1996;103(8-9):987-1041. doi: 10.1007/BF01291788. J Neural Transm (Vienna). 1996. PMID: 9013391 Review.
A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A(2A) receptor antagonists.
Pinna A, Morelli M. Pinna A, et al. Neurotox Res. 2014 May;25(4):392-401. doi: 10.1007/s12640-013-9446-8. Epub 2013 Dec 10. Neurotox Res. 2014. PMID: 24323318 Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science